Hemab Therapeutics Inc. COAG on Sunday presented new clinical data for its lead candidate HMB-002 in Von Willebrand disease ...

Incyte Corporation INCY on Monday reported complete Phase 1/2 multidose data for latarcibart (VGA039), showing substantial ...

Incyte (Nasdaq: INCY) today announced complete safety and efficacy data from all patients (n=16) enrolled in the Phase 1/2 multidose study of VGA039 (latarcibart), a novel, Protein S-targeting, ...

(Family Features) Many people don’t think much about whether their blood is clotting properly. However, when you have a bleeding disorder, a condition that affects the way your body controls clots, it ...

Pfizer said its experimental gene therapy for a rare genetic blood-clotting disorder succeeded in a large late-stage trial, paving the way for a potential approval. The hemophilia A treatment could ...

Pfizer Inc.’s gene therapy for a severe bleeding disorder met its goal in a pivotal late-stage trial, paving the way for the company to enter what’s proven to be a challenging market for drug ...

A clinical trial supported by the National Institutes of Health (NIH) was stopped early after researchers found sufficient evidence that a drug called pomalidomide, which is used to treat bone marrow ...

Hereditary hemorrhagic telangiectasia (HHT) is the second most common inherited bleeding disorder worldwide, affecting one in 3,800 persons. HHT's hallmark symptom is chronic nosebleeds, which often ...

Noncancerous blood disorders are conditions that affect blood cells, such as red blood cells, white blood cells, and platelets. Blood disorders may cause symptoms and complications, but most are ...

Bleeding Disorder Testing Market Driven by Rising Adoption of Reagents & Consumables, Expanding Hospital Procurement, Hemophilia Testing Demand, and Regulatory-Compliant Diagnostic Infrastructure to ...

Then, a few days later, I went to change Carson’s diaper in the middle of the night. It was filled with blood! He’d been circumcised after his birth in the hospital, and the wound had been healing ...